Related Experiment Video
Updated: Jul 13, 2026

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
Identification of TBC7 having TBC domain as a novel binding protein to TSC1-TSC2 complex
Akio Nakashima1, Ken-ichi Yoshino, Takafumi Miyamoto
1Biosignal Research Center, Kobe University, Kobe 657-8501, Japan.
Abstract:
TBC7, a TBC (Tre-2/Bub2/Cdc16) 1 domain protein, was identified as a novel binding protein to the TSC1-TSC2 tumor suppressor complex by peptide mass fingerprinting analysis of the proteins immunoprecipitated with FLAG-epitope tagged TSC1 and TSC2 from the transfected mammalian cells. The in vivo and in vitro association of TBC7 and the TSC1-TSC2 complex was confirmed by the co-immunoprecipitation and pull-down analysis, respectively, and TBC7 was revealed to bind to the C-terminal half region of TSC1, which is distinct from the binding site with TSC2. The immunofluorescence microscopy and subcellular fractionation showed that TBC7 co-localizes with the tumor suppressor complex in the endomembrane. Overexpression of TBC7 enhanced ubiquitination of TSC1 and increased phosphorylation of S6 protein by S6 kinase, that is located in the mTOR-signaling pathway. These results indicate TBC7 could take a part in the negative regulation of the tumor suppressor complex through facilitating the downregulation of TSC1.
Insights
TBC7 protein binds to the TSC1-TSC2 tumor suppressor complex, affecting its regulation. This novel interaction enhances TSC1 ubiquitination and influences the mTOR signaling pathway, suggesting TBC7 negatively regulates the tumor suppressor complex.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- The TSC1-TSC2 complex is a critical tumor suppressor regulating cell growth via the mTOR pathway.
- Understanding novel regulators of the TSC1-TSC2 complex is crucial for cancer research.
Purpose of the Study:
- To identify and characterize novel binding partners of the TSC1-TSC2 complex.
- To elucidate the functional role of TBC7 in the regulation of the TSC1-TSC2 tumor suppressor complex.
Main Methods:
- Peptide mass fingerprinting and co-immunoprecipitation to identify and confirm protein interactions.
- Pull-down assays to map binding regions.
- Immunofluorescence microscopy and subcellular fractionation for localization studies.
- Analysis of ubiquitination and protein phosphorylation in the mTOR pathway.
Main Results:
- TBC7 was identified as a novel binding protein to the TSC1-TSC2 complex.
- TBC7 binds to the C-terminal region of TSC1, distinct from the TSC2 binding site.
- TBC7 co-localizes with the TSC1-TSC2 complex in the endomembrane.
- Overexpression of TBC7 enhances TSC1 ubiquitination and S6 protein phosphorylation via S6 kinase in the mTOR pathway.
Conclusions:
- TBC7 interacts with and co-localizes with the TSC1-TSC2 tumor suppressor complex.
- TBC7 facilitates TSC1 ubiquitination, suggesting a role in TSC1 downregulation.
- TBC7 may negatively regulate the TSC1-TSC2 complex, impacting the mTOR signaling pathway.
Related Concept Videos
TGF - β Signaling Pathway
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Receptor Tyrosine Kinases
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

